Ken Nelson
Heart Rhythm Society (Hrs) Innovation Advisory Board & Task Force @Heart Rhythm Society
Signup · Get unlimited contacts
WORK HISTORY
Heart Rhythm Society (Hrs) Innovation Advisory Board & Task Force @Heart Rhythm Society
Dallas, TX, US
Driving innovation is a key tenant of the Heart Rhythm Society’s (HRS) strategic plan. As home to leaders in the field of heart rhythm care, HRS is uniquely positioned to serve as a conduit for individuals unified in the pursuit of advanced solutions in the care of patients.* HRS recognizes that to drive innovation, new approaches are necessary. HRS launched HRX in September 2022 initially focused on cardiovascular digital health. Over the last couple of years, HRX has become an incubator for cardiovascular innovation for those who are keen on learning about cutting-edge breakthroughs and opportunities, exchanging insights, and engaging in meaningful discussions that excite their intellect and awaken their curiosity.* Continuing to build on the stepping stone laid by HRX, the Innovation Panel will provide strategy and direction on the HRS Strategic Plan pillar to Drive Innovation
EDUCATION
Vanderbilt University
Bachelor of Arts, Economics, Business Administration, and Spanish
SKILLS
ABOUT KEN NELSON
Focused on people and culture and led commercial efforts for disruptive technologies in the digital health, wearables, and cardiac remote patient monitoring industries, playing a significant role in building the teams and cultures for 3 of the top 4 market share players, including #1 (BioTelemetry),#2 (iRhythm), and #4 (Bardy Diagnostics). Overall, I’m a 20 year digital health, medical device, and remote monitoring innovator with successful senior leadership experience ranging from a Fortune 500 company (Boston Scientific) to a medium sized #1 market share (Biotelemetry, acquisition by Philips for $2.8 Billion in December \'20) to 3 start-ups, 1 of which eventually led to an extremely successful IPO (iRhythm) and another which was acquired by HillRom (Bardy Diagnostics) in August \'21 for what will end up being $400M+ after milestone payments.Along the way I accomplished the following achievements most recently:• Built the teams, culture, and infrastructure, as well as developed the strategies and executed on the business plans to help drive global commercialization efforts of a disruptive cardiac monitoring patch (CAM Patch), resulting in multiple rounds of venture capital, including a $35M+ round in April 2019.• Raised significant shareholder value as well as a combined $100M+ in venture capital funding for iRhythm and Bardy Diagnostics, leading successful commercialization efforts for both by focusing on recruiting the right people, building the right culture, and developing strategic plans that led to explosive growth. • Led Biotelemetry to profitability for the first time ever, and grew them to the #1 market share player, in part by developing a winning team and culture to successfully grow revenue for 18 consecutive quarters from in revenue in 2012 to $208M in revenue in 2016, exceeding quota in all 18 quarters. • Drove successful acquisitions of competitors and emerging technology, as well as developed impactful strategic partnerships, all of which added to the explosive growth of these companies. Specialties: Sales and marketing leadership, management, building winning teams and cultures, commercialization and scaling of start-ups, venture capital fundraising, business planning, medical device sales, disruptive new product launches, Cardiology and Electrophysiology implantables and diagnostics, National Accounts, market development, marketing, recruiting and hiring sales talent, people development, contracting (negotiating and deal structuring), finance, strategic operations, strategic pricing, budgeting, and forecasting. Exit
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.